MED Medtronic Inc

In 1966, Medline was founded with a vision to make healthcare run better by providing clinical and supply chain expertise. What started as a medical supplies manufacturer has evolved into the largest provider of medical-surgical products and supply chain solutions, serving healthcare providers across the entire continuum of care. Today, Medline offers over 300,000 medical products with the capability to ship within one day to 95% of the United States, supporting hospitals, nursing homes, surgery centers, and home care agencies. Medline's roots actually date back to 1910 when A.L. Mills, the great grandfather of the current owners, started the Northwestern Garment Factory sewing aprons in Chicago. This foundation of manufacturing excellence has propelled the company to become a global healthcare leader with over $25 billion in net sales and 43,000 employees worldwide. Through unique offerings that combine quality products, innovative solutions, and operational expertise, Medline continues to transform how healthcare is delivered, making it more efficient, effective, and accessible for everyone involved in patient care.

ZOLL Medical Corporation, an Asahi Kasei company, develops and markets medical devices and software solutions that advance emergency care and save lives while increasing clinical and operational efficiencies. Named after Dr. Paul M. Zoll, a pioneer in cardiac pacing and defibrillation, the company has built a comprehensive portfolio spanning defibrillation, cardiac monitoring, circulation enhancement, CPR feedback, ventilation, therapeutic temperature management, and sleep apnea diagnosis. ZOLL serves first responders, hospitals, military personnel, and lay rescuers worldwide with technologies designed to improve patient outcomes in the most critical moments. With products for emergency care, critical care, and cardiac patient management, ZOLL provides innovative solutions including automated external defibrillators, wearable defibrillators, automated CPR devices, monitors/defibrillators, ventilators, and data management software. The company's mission is rooted in its founding commitment to resuscitation science, offering solutions that empower clinicians and responders to deliver better care when lives are on the line. ZOLL's portfolio includes the LifeVest Wearable Cardioverter Defibrillator, Heart Failure Management System, and WatchPAT Sleep Apnea Solutions.

In 1983, founder David Evans Shaw started IDEXX with just five employees in Portland, Maine, responding to a new niche market: the detection of diseases in livestock and poultry. What began as a focused diagnostic solution provider for the agricultural industry has evolved into something far more transformative - a global leader in pet healthcare innovation. The company recognized early on that veterinarians needed better tools to deliver optimal care, and this insight drove expansion beyond livestock testing into companion animal diagnostics, software, and comprehensive veterinary practice solutions. Today, IDEXX serves veterinarians worldwide with an integrated ecosystem that includes reference laboratories, in-house diagnostic analyzers like Catalyst One and ProCyte Dx, practice management software such as Cornerstone, Neo, and VetConnect PLUS, and educational resources through the IDEXX Learning Center. The company's roughly 11,000 employees across 80+ countries are united by a single mission: helping pets lead longer, fuller lives by giving veterinarians the clarity and answers they need. From pioneering SDMA testing for early kidney disease detection to developing digital cytology platforms that connect veterinarians with pathologists globally, IDEXX has consistently pushed the boundaries of what's possible in veterinary diagnostics, making advanced care accessible to practices of all sizes.

At Enterra Medical, we believe in restoring more than just physical symptoms - we believe in giving people their lives back. Our team is singularly focused on helping patients with chronic gastroparesis find relief through the Enterra® Therapy system, a groundbreaking gastric electrical stimulation approach. We were founded in 2022 with a specific mission: to advance technology, expand clinical science, and accelerate access to this life-changing therapy. With over 15,000 patients already treated, we know our work makes a tangible difference in people's daily lives. Our culture is defined by relentless dedication to patient outcomes and scientific rigor. Originally developed by Medtronic and FDA-approved in 2000, Enterra Therapy is now in the hands of a team that lives and breathes gastroparesis treatment. We collaborate closely with healthcare providers, from implanting surgeons to referring gastroenterologists, ensuring every patient receives comprehensive support throughout their journey. Our engineers and medical professionals work together to continuously improve our implantable neurostimulation technology, which delivers mild electrical pulses to reduce nausea and vomiting. We are not just manufacturing devices - we are providing hope for patients who have exhausted other treatment options.

In 2008, Jack Newton and Rian Gauvreau founded Clio with a simple but powerful realization: the legal profession was being left behind by the cloud computing revolution that was transforming every other industry. Lawyers were trapped in a world of paper files, disparate software systems, and inefficient practices that made it harder to serve clients effectively. They saw an opportunity to modernize legal practice through cloud-based technology that would be accessible, affordable, and transformative. What started as a small Canadian startup has grown into the world's leading provider of cloud-based legal technology. Today, Clio powers law firms of all sizes across the globe, from solo practitioners to large enterprises. Headquartered in Greater Vancouver with teams spanning Calgary, Toronto, Dublin, Manchester, and Sydney, Clio continues to set the global standard for innovation in legal tech. The company's mission remains clear: to transform the legal experience for all by equipping lawyers with secure, intuitive tools that help them work more effectively, grow profitably, and deliver exceptional client service.

In 2023, three founders with deep roots in engineering and logistics realized something profound: while AI was transforming consumer technology, the industries that move our physical world - supply chains, freight, logistics - remained stuck in manual, inefficient processes. Pablo Palafox, his brother Javier Palafox, and Luis Paarup saw that these real-economy businesses were drowning in repetitive communication tasks: endless phone calls to book loads, check shipments, and coordinate schedules. They understood the solution wasn't just better chatbots, but an AI-native operating system that could truly handle end-to-end work with human-like intelligence. So they built HappyRobot - an AI workforce platform that doesn't just augment human workers but autonomously manages complex operations across phone, email, messaging, and documents. Starting with logistics and industrial operations, HappyRobot has grown rapidly, deploying AI workers across over 150 enterprise customers including DHL and Ryder. With $62 million in funding from top-tier investors like Y Combinator and Andreessen Horowitz, the company is now expanding to redefine how the real economy operates, freeing humans to focus on strategy and creativity while AI handles the patterned work at scale.